Everest Group Slips Into Q3 Print as Retail Attention Spikes
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Everest Group fell 1.1% on Wednesday to $386.88, down 2% on the week, underperforming a peer group whose median weekly move was -0.5%. The stock reports Q3 results today.
The most unusual data point heading into the print is a spike in retail attention. Wikipedia pageviews for Everest Group carry a z-score of 2.6 against the company's own 90-day history, the highest attention reading in the tracked window. That kind of retail interest is more often associated with a catalyst or controversy than with a quiet reinsurer. It does not indicate direction, but the attention is real and worth noting.
Options positioning has drifted modestly more defensive since the previous preview on October 25 flagged an unusually call-heavy setup, but the change is small. The put/call ratio ticked up to 0.38, marginally above its 20-day average of 0.37 and about half a standard deviation above it. That is close to neutral territory, well below the fearful readings the ratio has hit during this year's most volatile episodes (the 52-week high reached 2.03). The lending market remains completely relaxed. Availability in the borrow pool is over 3,100% of short interest, meaning shares are easy to obtain for anyone wanting to short. Short interest itself has continued to ease, down nearly 4% on the week and roughly 3% over the past month, to 3.9% of the free float.
The analyst debate is genuinely split on what to expect from the underwriting cycle. The bull case rests on improving loss ratios, reinsurance property rate tailwinds, and management's active effort to remediate the insurance segment's expense profile. The bear case centres on social inflation: if reserve assumptions are too optimistic, casualty lines could produce adverse development that eats into book value. RBC Capital initiated with an Outperform and a $455 target in late September, the most aggressive stance on the Street. Keefe, Bruyette & Woods and Mizuho both trimmed targets in October, to $407 and $398 respectively, while holding their existing ratings. The consensus mean sits at $410, about 6% above the current price. Valuation is undemanding: the stock trades at 0.84 times book value and 6.5 times trailing earnings, well inside what the sector typically commands. The factor scores reflect that cheapness, with earnings yield and EV/EBIT each ranking above the 70th percentile.
The one earnings reaction on record shows the stock fell 5% the day after July's Q2 print and extended the loss to 6% over the following five sessions. That quarter caught investors off-guard on loss experience. The Q3 print will test whether the remediation steps management described in July are showing up in the combined ratio, and whether social inflation trends in the US casualty book have stabilised enough to support current reserve levels.
Stocks in this article
See the live data behind this article on ORTEX.
Open EG on ORTEX →How this article was generated
- Generated
- 29 Oct 2026, 04:18
- Data as of
- 29 Oct 2026, 04:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.